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Objectives: to investigate the specific humoral immune response to three different polyester (Dacron) prostheses in pigs.
Design, materials and methods: twenty-four growing pigs were randomly divided into three groups. The infrarenal
aorta was replaced by a segment of collagen-impregnated woven polyester prosthesis (low, medium and high porosity).
Serum antibodies were detected by modified enzyme immunoassay using non-impregnated prosthesis as the target for the
blood samples taken on experimental days 1, 10, 17, 24, 62 and 116 of the 22 pigs followed over the whole observation
period.
Results: significantly enhanced (p<0.05) mean IgG antibody binding against polyester was detected on experimental
days 10, 17, 24 and 62 with antibody prevalences of 41%, 41%, 32% and 37%, respectively. Antibody positive pigs were
divided into early responders (n=9) and late responders (n=5) with antibody detection on day 10 and/or 17 vs day 62
and/or 116. No significant differences between the three different prostheses were found. The formation of specific IgG
antibodies against polyester in the animals investigated demonstrates a broad individual variability.
Conclusions: polyester is an antigenic polymer. Specific antibodies, reflecting the inflammatory response, might be not
only a parameter for testing biomaterials but also for determining individual bio(in)compatibility for long-term biomaterial
function.
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Introduction mechanisms might be involved, including the co-
agulation system, the complement cascade,10 phago-
Polymeric biomaterials were considered to be com- cytosis and immunological responses.11 The activated
phagocyte seems to play the central role in thesepletely inert over a long period. However, in-
vestigations on explanted prostheses have shown processes.12–16 Moreover, the individual immune re-
sponse to a given immunogen (biomaterial) dependsdestruction of the polymer matrix.1,2 Initial matrix
alteration was ascertained by transmission electron on the age and health of the recipient and shows a
broad variability, as demonstrated by immunisationmicroscopic studies 4 weeks after implantation in an
animal model.3 Chronic inflammation was found to in inbred animal studies.
Following our previous detection of polymer anti-cause hydrolysis and/or auto-oxidation of the vascular
prosthesis matrix with consecutive destruction and the bodies in rats and mice after repeated implanta-
tion,17–19 the aim of the present study was to investigaterelease of polymer particles,4,5 reflecting the bio-
degradation of the polymer matrix.6–8 The in- the specific humoral immune response after a single
implantation of three different collagen-impregnatedflammatory process is accompanied by a variety of
different cell-biomaterial and cell-to-cell interactions polyester prostheses in growing pigs.
in blood and tissue, leading to a highly aggressive
microenvironment especially for polymers.9 The com-
plete range of non-specific and specific host defence Materials and Methods
Animals and implantation procedure
∗ Please address all correspondence to: R. Zippel, Department of Twenty-four 10-week-old female pigs weighing be-Surgery, Carl Thiem Hospital, Thiem Street 111, Cottbus, D-03048,
Germany. tween 24 and 29 kg were randomised into three groups.
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Table 1. Prostheses specifications. (ELISA) with modifications20 for detection of anti-
bodies against polymeric membranes and a modi-M-prosthesis (Hemashield Microvel Double Velour – HMDV):
woven, crimping, double velour, impregnation with bovine fied cellular ELISA for detection of cell surface anti-
collagen type 1, primary porosity 160–360 cm3/min/cm2, porosity gens.21,22
after impregnation <10, 1 cm3/min/cm2 The specificity of polymer antibody binding was
C-prosthesis (Cooley Low Porosity – CLP): woven, crimping, no tested by preincubation of one serum sample of eachvelour, additional impregnation with bovine collagen, type I,
antibody positive pig (dilution 1:100) with suspensionprimary porosity <50, 1 cm3/min/cm2, porosity after
impregnation <10, 1 cm3/min/cm2 of polyester particles. After 8 h at 4 °C the supernatants
were analysed in the enzyme immunoassay as de-T-prosthesis (Touch down – TD): woven, no crimping, no velour,
impregnation with bovine collagen type I, primary porosity scribed above.
500–750 cm3/min/cm2, porosity after impregnation <10, 1 cm3/
min/cm2
Enzyme immunoassay for determination of serum IgG
content
The serum IgG content for the pigs investigated was
The infrarenal aorta was resected and replaced by a analysed by a modified ELISA, described in detail by
4 cm long segment of variously constructed, collagen- Schlosser.23
impregnated, woven Polyester (Dacron, a trademark of
Dupont et Nemours; Haemashield; Meadox Medicals
Inc., Oakland, NJ, U.S.A.; prostheses specifications
shown in Table 1) with a diameter of 8 mm. Im- Data analysis
plantations were performed under sterile conditions
with general anaesthesia according to the ‘‘Principles of The data are presented as mean±standard deviation
Laboratory Animal Care’’ (formulated by the National (SD) of triplicates at a serum dilution of 1/100 for the
Society for Medical Research) and the Guide for the 22 pigs followed over the whole observation time. The
Care and Use of Laboratory Animals (NIH Publication cut-off for antibody positivity was calculated from the
No. 86-23, revised 1985). During the observation time, mean of IgG antibody binding for all the pigs on
one animal died of cardiac failure and another of experimental day 1 at a confidence interval of 95%.
marasmus (two groups of seven and one group of Student two-tailed t-test and Mann–Whitney U-test
eight animals). Blood samples were taken from the were used to analyse significant differences between
ear vein on experimental days 1 (day of implantation), the mean values of antibody binding, and the non-
10, 17, 24, 62 and 116. Serum was separated and stored parametric Spearman test to calculate correlations be-
at −20 °C. tween polymer antibody binding and serum IgG con-
tent. p-values are given at a confidence interval of
95%. The statistical analysis was performed with the
SPSS software version 8.0 (SPSS GmbH Software,
Detection of polymer antibodies Munich, Germany).
Homogenisation of polyester prosthesis
One gramme of non-impregnated polyester prosthesis
(Microvel Double Velour, Meadox Inc., Oakland, NJ, Results
U.S.A.) was cut (pieces of 0.4 mm2) and homogenised
on ice by Ultra-Turrax (MICCRA D-13, ART moderne Fourteen animals (64%) (Fig. 1) showed significant
Labortechnik, Mu¨hlheim, Germany) in phosphate-buf- antibody formation once over the whole observation
fered saline (PBS) containing 0.1% Tween 20 and 0.09% time. The highest antibody prevalence and mean anti-
NaN3. The resulting suspension contained 8.2×107 body binding against the polyester polymer was ob-
polymer particles per ml with an average size of 0.5 tained on experimental day 10 and 17 in nine animals
to 50 m. Only 2.4% of all particles were smaller than (41%). Seven animals (32%) were found to be antibody
0.5 m. positive on experimental day 24 and eight animals on
day 62 (37%). Only three pigs (14%) showed a sig-
nificant antibody binding 116 days after the im-Enzyme immunoassay for detection of anti-polyester
serum antibodies plantation. Significant differences of mean antibody
binding compared to experimental day 1 were detectedDetection of IgG antibodies against the implanted
polyester prostheses was performed by a previously on days 10, 17, 24, and 62 (p<0.05), but not on ex-
perimental day 116.described enzyme-linked immunosorbent assay
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Fig. 1. IgG polyester antibody binding in 22 pigs vs time. (Horizontal
line indicates cut-off for antibody positivity, significance compared
to experimental day 1. ∗p<0.05; Mann–Whitney U-test).
The responders can be divided into early responders
(n=9; 41%), with a significantly enhanced antibody
formation already on experimental day 10 and/or 17,
and late responders (n=5; 23%); the latter were only
antibody positive on experimental day 62 and/or 116
(Fig. 2). After the fast and high antibody formation
described above, the early responders showed a de-
creasing antibody prevalence and binding on ex-
perimental days 62 and 116. Only four pigs of this
group were found to be antibody positive on ex-
perimental day 62 and one pig on day 116. Significant
antibody binding compared to experimental day one
was detectable in the group of early responders on
days 10, 17 and 24 (p<0.001). In addition, significant
differences in antibody formation between early and
late or non-responders were found on experimental
days 10, 17 and 24, but not on days 62 and 116. Late
responders showed a significant antibody binding in
accordance with their definition on days 62 and 116
(p<0.05) compared to day one.
No differences were found for the immunogenicity
of the different prostheses implanted, as shown in Fig.
2. The implantation of M-, C- or T-prostheses induced
comparable antibody formation; in each prosthesis
group, the animals could be subdivided into early, late
or non-responders.
One serum sample of each antibody positive pig
(dilution 1/100) was preincubated with a suspension
Fig. 2. IgG polyester antibody binding in individual pigs vs timeof polyester particles before the samples were analysed classified regarding their antibody response against polyester as
in the polyester-ELISA to evaluate the specificity of early (Fig. 2a), late (Fig. 2b), and non-responders (Fig. 2c) (Horizontal
line indicates cut-off for antibody positivity.)the polymer antibodies detected. This preincubation
reduced the individual antibody binding against poly-
ester in average by 74.9±10.9% (data not shown). 17 vs 18.8±4.7 mg/ml on day 116. Futhermore, there
was no significant correlation between polymer IgGNo age-dependent variation was found for the
serum IgG content in the animals investigated, e.g. binding and the serum IgG concentration in the
animals investigated (data not shown).20.1±5.6 mg/ml on day 1 vs 19.8±7.0 mg/ml on day
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Discussion experimental day 116 compared to all mice 248 days
after the third implantation on experimental day 38.19
After the implantation of a polmeric vascular pros- It can be assumed that such increasing antibody for-
mation/prevalence after repeated antigen im-thesis, the periprosthetic tissue showed a typical for-
eign body reaction with the accumulation of plantation, resembling a booster effect, could also be
demonstrated after repeated antigen presentation ininflammatory cells in the early phase and later the
formation of foreign body giant cells and the secretion the pig model. An increasing immune response can
be further achieved by the polyclonal activation of theof extracellular matrix.24–27 The early inflammatory re-
sponse is known to be induced by cellular reactions immune system using complete Freund’s adjuvant
(CFA), containing heat-killed mycobacteria, whichmediated by macrophages and T-lymphocytes.15,16 The
importance of humoral responses in the formation of simulates a bacterial infection or an inflammatory
response.15,19,30 These findings demonstrate the import-antibodies against the prosthetic matrix and/or the
coating is still a matter of controversy. The antigenicity ance of the sterility of implants in general.
Regarding the kinetics of antibody formation, pigsof a polymer implant (silicone) was first described by
Goldblum 1992 in two patients with inflammatory could be divided into three groups, i.e. early re-
sponders, late responders and non-responders. Thereaction after the implantation of a ventriculo-
peritoneal shunt compared to an asymptomatic control highest antibody prevalence was found on ex-
perimental days 10 and 17. This high antibody for-group.28 Furthermore, the immunogenicity of polymer
implants with the formation of specific humoral anti- mation is typical of the early responder group and
persisted up to experimental day 24 in seven of the ninebodies was demonstrated by Schlosser and Ziegler
after the implantation of different polyurethanes, cel- pigs, although with reduced antibody titre (p<0.001 vs
day 1).lulose acetate, polytetrafluoroethylene (PTFE) and po-
lycarbonate in rats.17,29 In line with these results, our The second group, comprising five animals as late
responders, were antibody positive only on ex-previous investigations have shown antibody for-
mation in inbred rats and mice after the repeated perimental days 62 and/or 116 (p<0.05 vs day 1). Thus
different immune reactions of pigs might reflect anintraperitoneal implantation of segments of polyester
prostheses.18,19 individual inflammatory response of the receipients,
and this has been also demonstrated by immunisationThe present study aimed to investigate the humoral
immune response after a single functional im- experiments in inbred animals performed with defined
antigens.19plantation in the pig animal model, known to be more
similar to the human system than rodents with regard The specificity of polymer antibodies was evaluated
with three strategies. Firstly, polymer antibody bindingto immunological reactions. Therefore, three collagen
impregnated vascular prostheses with different por- was significantly reduced by the preincubation of
serum dilutions with polyester suspension followedosity, which are frequently used in vascular surgery,
were implanted. The results presented show a specific by analysis of supernantants in the polymer particle
enzyme immunoassay. Secondly, the time course ofIgG antibody formation against the polymer matrix
(polyester) in growing pigs which was independent polymer antibodies was not associated with the time
course of serum IgG contents of the animals. Fur-on porosity and the construction of the prosthesis
implanted, e.g. no significant difference was found thermore, no significant correlation was found be-
tween serum IgG content and polymer antibodybetween M-, T- or C-prosthesis. The theoretical co-
detection of collagen antibodies induced due to the binding for individual pigs. Thirdly, a possible de-
tection of antibodies induced against the coating sub-prosthesis impregnation was excluded by using a bare
non-impregnated prosthesis homogenate from the stance of prostheses – bovine collagen type I in the
case of our investigations – was excluded by using asame company as target in the assay which failed
to bind collagen antibodies. In accordance with our non-impregnated prosthesis from the same company
as an antigenic target in the immunoassay. Theseprevious investigations on inbred rats and mice, show-
ing antibody positivity in all animals after a single results correspond to our previous findings for rodents
which showed no reduction of polymer antibody bind-polymer implantation, an early induction of immune
response was also found in growing pigs after a single ing after the addition of bovine collagen type I,18,19
However, it cannot be excluded that, beside polymerimplantation on experimental day 10 when 41% of the
animals were antibody positive. A significant antibody antibodies, collagen antibodies are also present in sera
which are, however, not detectable by our assay.formation was detectable up to day 62 compared with
day 1. Only three pigs were antibody positive on The nature of polymer antigens is not yet known,
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